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Abstract.  L6J1  rat myoblasts and rat skeletal muscle 
were studied for expression of mRNAs encoding 
PDGF A-chain,  PDGF B-chain,  PDGF o~-receptor, 
and PDGF B-receptor during  in vitro and  in vivo myo- 
blast differentiation.  RNA blot hybridizations demon- 
strated expression of the PDGF A-chain gene and the 
PDGF ~receptor gene in L6J1  myoblasts and  in crude 
muscle tissue isolated from developing rats.  Tran- 
scripts of the PDGF A-chain were identified at all  ex- 
amined stages of in vitro and in vivo myogenic 
differentiation.  Expression of the PDGF B-receptor 
gene decreased in differentiated myotubes of L6J1  cells 
and in rat adult muscle tissue. Receptor binding assays 
demonstrated specific binding of PDGF-BB, but not 
-AA, to exponentially proliferating  L6J1  myoblasts and 
to terminally differentiated L6J1 myotubes. The bind- 
ing per cell nucleus was higher in exponentially 
proliferating myoblasts than  in differentiated L6J1 
myotubes. In serum free medium PDGF-BB was 
shown to increase c-fos protooncogene immunoreac- 
tivity in L6J1  myoblasts. In the presence of 0.5%  FCS, 
PDGF-BB increased DNA synthesis in L6J1 myo- 
blasts, while PDGF-AA showed no such effect. 
Differentiation,  as monitored by myotube formation, 
was reduced in PDGF-BB-treated cultures.  The possi- 
ble role of PDGF in myoblast proliferation and 
differentiation is discussed. 
M 
YOGENESIS is  the differentiation  of proliferating 
skeletal  myoblasts  to form  contractile,  multinu- 
cleated  myotubes (for  review,  see  Pearson  and 
Epstein,  1982). This process involves cessation of DNA syn- 
thesis, cell surface changes, cell-cell recognition of Go myo- 
blasts  and  fusion of such cells into giant,  multinucleated 
myotubes  that  synthesize  contractile  proteins  typical  for 
skeletal  muscle. In the developing  rat, this process occurs 
mainly at the time of birth (Yaffe, 1973). Already in 10-d-old 
rats,  the majority of myoblasts  have fused into myotubes. 
Thereafter,  muscle growth occurs mainly from enlargement 
of preexisting  myotubes. 
When myoblasts become confluent  in culture,  DNA syn- 
thesis is inhibited (Yaffe, 1971), and RNA synthesis is reduced 
(Yaffe and  Fuchs,  1967).  Several  studies  have suggested  a 
causal  relation  between terminal  myogenic  differentiation 
and regulation  of DNA synthesis in myoblasts. Deprivation 
of mitogens brings  about precocious myogenic differentia- 
tion (Nadal-Ginard,  1978), and stimulation  of DNA synthe- 
sis in mouse myoblasts by fibroblast growth factor delays the 
onset of myotube formation  (Linkhart  et al.,  1980; Ewton 
and Florini,  1981). A variant  mouse myoblast cell line re- 
sponds by proliferation  and delayed fusion to treatment with 
epidermal growth factor as well (Lim and Hauschka, 1984), 
and more recently,  type 13 transforming  growth  factor was 
also shown to inhibit myogenic differentiation  (Massagu6 et 
al., 1986). On the other hand, glucocorticoids and members 
of the insulin family, such as insulin,  insulin-like growth fac- 
tors I and II stimulate both proliferation  and differentiation 
of rat myoblasts  (Guerriero and Florini,  1980; Ewton and 
Florini,  1981). 
To study further the role of mitogens in myoblast prolifera- 
tion  and  differentiation,  we  analyzed  the  expression  of 
PDGF genes and PDGF receptor genes during myogenesis. 
PDGF was originally  observed in platelets as a cationic 30- 
kD protein  with potent mitogenic effects on several mesen- 
chymal cell types, such as fibroblasts, gila cells, and smooth 
muscle cells (Heldin et al.,  1985; Ross et al.,  t~;86). Struc- 
turally,  PDGF is a dimer of two polypeptide chains  linked 
by disulfide bonds. The PDGF polypeptides are encoded by 
the PDGF A-chain gene and the PDGF B-chain gene (c-sis). 
PDGF has been identified in all three possible isoforms; AA, 
AB, and BB (Stroobant  and Waterfield,  1984; Heldin et al., 
1986; Hammacher et al.,  1988). The PDGF isoforms were 
recently shown to bind with different affinities to two distinct 
types of cell surface receptors (Claesson-Welsh et al., 1988; 
Escobedo et at.,  1988; Gronwald et al.,  1988; Hart et al., 
1988; Heldin et al., 1988; Claesson-Welsh et al., 1989; Mat- 
sui et al.,  1989). The PDGF a-receptor (also called A-type 
receptor) binds all three forms of PDGF with high affinity, 
while the  PDGF /~-receptor (also  called  B-type receptor) 
binds PDGF-BB with high affinity and PDGF purified from 
human platelets with lower affinity, but does not bind PDGF- 
AA.  We have previously demonstrated  that  secondary rat 
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express the PDGF A-chain gene, and that L6J1 myoblasts se- 
crete PDGF, most likely in the form of PDGF-AA (Sejersen 
et al., 1986a).  We now present further results on the expres- 
sion of PDGF A- and B-chains and PDGF t~- and/3-receptors 
during myogenesis in the developing rat and in L6J1 cells 
undergoing spontaneous in vitro myogenic differentiation. 
Effects of PDGF on c-fos protooncogene expression, DNA 
synthesis, cell proliferation, and myogenic differentiation are 
also presented. 
Materials and Methods 
Cell Cultures 
Myoblasts of the cell line L6J1 (Yaffe, 1968; Ringertz et al., 1978) were cul- 
tured in DME, supplemented with 5% FCS, as described previously (Sejer- 
sen et al., 1986a).  Medium was changed two or three times per week. For 
induction of myogenic differentiation, myoblasts were seeded at 6  x  103 
cells/era  2 in 60-cm  2 dishes and cultured for  10 d  without replating. For 
analysis of the effect of PDGF on myoblast differentiation, cells were seeded 
in 20-cm  2 dishes for 24 b, before being switched to serum poor medium 
(DME/0.5%  FCS) with or ~'ithout 25  ng/ml PDGF-BB.  PDGF-BB was 
added to the culture on a  daily basis for ten consecutive days, and the 
medium was changed every second day. 
For analysis of myoblast proliferation, cells were plated at 4  ×  103 
cells/cm  2 in 7-cm  2 wells in DME/5%  FCS. After serum deprivation for 
4 d,  myoblasts were cultured in 0.5%  FCS with or without 25 ng/ml of 
PDGF-BB. Cell numbers were counted each day in triplicate wells using 
an automatic cell counter (VDA  140; Analys Instrument AB, Sweden). 
Determination of  Myoblast Fusion 
Cultures to be scored for cell fusion were washed with PBS, fixed with 
methanol, and stained with giemsa. The percentage of nuclei in myotubes 
was estimated by counting 1,200-1,500  nuclei/plate in 8-10 fields chosen 
at random. Only structures containing three or more nuclei were scored as 
representing fused cells. 
Rat Skeletal Muscle Isolation 
Crude muscle tissues were isolated from thighs of Sprague-Dawley rats of 
the following ages: 15-, 17-, 18-, and 20-d-old rat embryos; 1-, 7-, 14-, and 
21-d-old rats, and from a 5-too-old (adult) rat. Whole hind legs of 15- and 
17-d-old rat embryos were used. For comparative purposes, whole 13-d-old 
rat embryos were used. Isolated tissues were minced by scissoring, immedi- 
ately frozen and kept in liquid nitrogen until RNA extraction. Crude muscle 
preparations may contain a small fraction of nonmuscte cells, mainly fi- 
broblasts. 
Purification and Blot Analysis of  Poly(A  )  +  RNA 
Purifications of total  RNA,  selections of poly(A)  + RNA, gel fractiona- 
tions, RNA blottings, RNA hybridizations, washing procedures, and deter- 
minations of sizes of transcripts and intensities of hybridization signals were 
performed essentially as described earlier (Sejersen et al., 1986b;  Rahm et 
al., 1989).  Concentrations of poly (A)  + RNA were measured and normal- 
ized  by  both  ethidium bromide-agarose plates  and  ultraviolet  spectro- 
photometry. 
D  NA Probes 
The  following probes were used:  the  1.3-kb  eDNA fragment of human 
PDGF A-chain clone D1 (Betsholtz et al., 1986),  human c-sis clone pSM-I 
(Clarke et al., 1984), and human c-sis clone PDGF-B-17  (Betsholtz, C., un- 
published observations), the 1.5-kb cDNA fragment of human PDGF tz-re- 
ceptor clone 15.3 pUC (Claesson-Welsh et al., 1989), the 1.0-kb Pst I eDNA 
fragment of human PDGF preceptor (Claesson-Welsh et al., 1988),  Psi l 
DNA fragments of mouse fast myosin heavy chain MHC 32 (Weydert et al., 
1983), mouse ct-actin pAM 91 (Minty et al., 1981), and chicken glyceralde- 
hyde-3-phosphate dehydrogenase eDNA  clone pGAD-28  (Dugaiczyk  et 
al.,  1983). 
PDGF 
PDGF-AA (short form) and PDGF-BB were recombinant human forms 
purified from a Saccharomyces cerevisiae expression system (Ostman et al., 
1989),  and were used for studies of PDGF binding and DNA synthesis. 
PDGF-AA and PDGF-BB were t~SI-labeled using the Boiton and Hunter 
protocol (BoRon and Hunter, 1973) to specific activities of 13,000 (PDGF- 
AA) and 21,000 (PDGF-BB) cpm/ng. 
Porcine PDGF-BB (Boehringer Mannheim OmBh, FRO) was used for 
studies of c-fos induction, cell proliferation, and cell differentiation. 
Receptor Binding Assays 
Binding experiments were performed on L6Jl  myoblasts cultured in 2-cm  2 
wells. Each well contained ~70,000 myoblasts or 500,000 nuclei of myo- 
tubes. Cells, with or without pretreatment of 500/.,g/ml of suramin (Bayer 
AG, Wuppertal, FRG) for 30 min at 4°C, were rinsed with binding buffer 
(PBS containing 0.1% BSA, 0.9 mM CaCI2  x  2H20, and 0.8 mM MgSO4 
x  7H20).  Myoblast cultures were then incubated for 3 h at 4°C in 0.5 ml 
binding buffer containing 4 ng/ml of 1251-labeled PDGF isoforms, with or 
without 300 times excess of the corresponding unlabeled ligand. Cultures 
were thereafter washed five times in ice-cold binding buffer. Myoblasts with 
associated 1251-radioactivity were lysed by  incubation in 0.5  ml of lysis 
buffer 0% Triton X-lO0/iO%  glycerol/20 mM "Iris, pH 7.4) for 30 min at 
room temperature, and radioactivity was determined in a gamma spectrom- 
eter (1282 CompoGamma, LKB Wallac,  Sweden). L6JI cell numbers were 
determined in parallel cultures by counting giemsa-stained cell nuclei using 
a  Zeiss light microscope. 
c-fos lmmunofluorescence Assay 
c-fos  immunofluorescence assay was performed as described previously 
(Rahm et al., 1989). xfos-3 rabbit polyclonal antibodies against amino acid 
residues 2-17 of human/mouse p55 c-fos (Hunt et al.,  1987),  provided by 
Dr.  G. Evan, were used at  1:500 dilution in PBS/0.5% Triton X-100. For 
specific  blocking  of c-fos  immunofluorescence xfos-3  antibodies  were 
preincubated for 3 h at room temperature with an excess of synthetic pep- 
tides covering amino acid sequence 2-17 of human/murine c-fos (OP-I 1- 
3210;  Cambridge Research Biochemicals, UK). The nuclear fluorescence 
was visualized using a Zeiss ultraviolet microscope, and the optical density 
of the fluorescence was scanned using a Zeiss/Kontron IBAS 2000 interac- 
tive image analysis computer. 
DNA Synthesis Assay 
Fractions of cells undergoing DNA synthesis were measured by studying 
incorporation of bromodeoxyuridine (BrdU)  I in  proliferating myoblasts. 
L6JI myoblasts were seeded on coverslips and serum-deprived in DME/0% 
FCS for 4 d. Thereafter, 10 #M of BrdU was added, with or without various 
concentrations of PDGF-AA or -BB, for 24 h. After fixation in 70 % ethanol 
for l0 d at 4°C, cells were treated with 0.07N  NaOH and 0.01M NazB407 
(pH 8.5)  for 2 rain.  Thereafter, mouse monoclonal anti-BrdU antibodies 
(Becton Dickinson Immunocytometry Systems, Mountain View, CA) were 
applied for 30 min at room temperature, followed by rhodamine-conjugated 
anti-lgG antibodies (Dakopatts a/s, Denmark), diluted t:10 in PBS, for 15 
rain at room temperature. Coverslips were mounted in PBS/glycerol (!:1), 
and  fractions  of  BrdU-incorporating nuclei  were  determined counting 
500-1,000  nuclei  in  randomly  selected fields of vision,  using  a  Zeiss 
ultraviolet microscope. 
Results 
PDGF  A-Chain mRNA Expression in Differentiating 
Rat Myoblasts 
PDGF A-chain gene expression has previously been reported 
in  L6JI  myoblasts and  in primary culture of rat embryo 
skeletal myoblasts (Sejersen et al., 1986a).  To elucidate fur- 
ther the expression pattern of the PDGF A-chain gene in 
I. Abbreviations used in this paper:  BrdU, bromodeoxyuridine; GAPDH, 
glyceraldehyde-3-phosphate debydrogenase; MHC, myosin heavy chain. 
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MHC, actin, and GAPDH transcripts in L6JI myoblasts at day 2 
to day 10 of spontaneous myogenic in vitro differentiation. 15/zg 
of poly A  ÷ selected RNA was analyzed in each lane. The same 
filter was sequentially hybridized to various DNA probes. Sizes of 
transcripts are shown in kilobase. Autoradiograph exposure times 
were 12 h for MHC and actin, 48 h for PDGF A-chain and PDGF 
~receptor, and 96 h for GAPDH. 
muscle  development,  we  analyzed messenger  RNA  from 
L6Jl cells and from rat skeletal muscle tissue at various time 
points of the differentiation process. 
In L6J1 myoblasts, expression of the PDGF A-chain gene 
was identified at all stages of the 10-d spontaneous in vitro 
differentiation process, although most abundantly at day 7, 
when the cells had undergone density-dependent arrest of 
DNA  synthesis and fused actively to form multinucleated 
myotubes. Myotube formation took place in parallel with the 
increase of 1.6-kb c~-aetin and 6.9-kb myosin heavy chain 
(MHC) transcripts (Fig. 1). No myotubes were present at day 
O, ,x,5-10% of the nuclei were present in myotubes at day 5, 
40-50% at day 7, and 70-80% after 10 d in culture. Expres- 
sion of PDGF A-chain gene 2.8-, 2.3-, and 1.9-kb transcripts 
increased almost six times from day 2 to 7 of the differentia- 
tion process before returning to lower levels in day 10 myo- 
tubes (Fig.  1). 
Expression of the PDGF A-chain gene was also demon- 
strated in crude muscle tissue obtained from developing rats. 
Transcripts were barely detectable in  13-d-old whole em- 
bryos but appeared clearly in hind legs of 15-d-old rat em- 
bryos (Fig. 2). The abundance of the PDGF A-chain gene 
2.3-  and  1.9-kb  transcripts  then remained fairly constant 
throughout muscle development, including adult rat muscle 
(Fig. 2). Some variations were seen in the less abundantly 
expressed 2.8 kb transcript. 
Expression of the PDGF B-chain gene (c-sis) was not de- 
tected in L6J1 myoblasts or in crude muscle tissue obtained 
from developing rats at any stage of the differentiation pro- 
cess, although the rat, genome did contain DNA sequences 
that hybridized to a human c-sis probe (not shown), support- 
ing previous results (Sejersen et al.,  1986a). 
PDGF  l~-Receptor mRNA Expression during Rat 
Myoblast Differentiation 
Hybridizing RNA filters bearing materials from in vitro and 
in vivo differentiating rat myogenic cells with DNA probes 
specific for the PDGF or- and B-receptors, we identified a 
5.3-kb PDGF/3-receptor gene transcript both in L6J1 myo- 
blasts and in rat muscle tissue. The relative abundance of  5.3- 
kb PDGF/t-receptor transcripts in L6J1 cells was inversely 
related to the appearance of the myogenic markers ot-actin 
and MHC  (Fig.  1).  Maximum expression was observed at 
day 3-4 of the spontaneous differentiation process when the 
growth rate of L6JI myoblasts was  exponential. The abun- 
dance rapidly declined when the cells became confluent. In 
day 10 L6J1 myotubes, PDGF/3-receptor mRNA was barely 
detectable, the relative abundance being nine times lower 
than at day 4  (Fig.  1). 
In crude muscle tissue obtained from developing rats, ex- 
pression of the PDGF ~-receptor gene showed kinetics com- 
parable to that of the PDGF A-chain gene (Fig. 2). The ex- 
pression was extremely low in 13-d-old whole embryos and 
in adult muscle tissue. Within the accuracy of the Northern 
technique used, a downregulation was seen around birth. Ex- 
pression of PDGF c~-receptor  transcripts was  not detected 
with the techniques employed, except for marginal levels in 
crude muscle tissue obtained from late stage rat embryos, 
which remains to be further confirmed (data not shown). 
RNA filters were hybridized also with a glyceraldehyde-3- 
phosphate dehydrogenase (GAPDH) gene probe (Dugaiczyk 
et al.,  1983).  Expression of this gene was constant during 
L6JI in vitro myoblast differentiation but appeared to be de- 
velopmentally regulated  in  crude  muscle  tissue  obtained 
from developing rats in vivo (Figs.  1 and 2). 
L6J1 Myoblasts Bind PDGF-BB 
'25I-iabeled  recombinant PDGF-AA and  -BB were used to 
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Figure 3.  Binding of 125I-labeled recombinant human PDGF-AA 
and -BB to exponentially proliferating (Prolif) L6JI myoblasts and 
differentiated (Diff) myotubes,  respectively. Cells  with (stippled 
bars) or without (open bars) pretreatment of suramin were rinsed 
with binding buffer,  and then incubated for 3  h at 4°C in binding 
buffer supplemented  with 4 ng/ml of tz~I-labeled PDGF-AA or -BB 
with (+) or without (-) 300 times excess of the corresponding un- 
labeled ligand. Ceil densities were determined in parallel cultures 
by counting Giemsa-stained cell nuclei using a  Zeiss light micro- 
scope.  The results are shown as mean values of triplicate cultures. 
Figure 2. RNA blot illustrating PDGF A-chain, PDGF B-receptor, 
MHC,  actin,  and GAPDH transcripts  in total embryo and crude 
muscle tissues isolated from thighs of Sprague-Dawley rats of dif- 
ferent ages. 9 #g of poly A ÷ selected RNA was analyzed in each 
lane.  The same filter was sequentially hybridized to various DNA 
probes. Sizes of transcripts are shown in kilobase. Autoradiograph 
exposure times were 12 h for MHC, actin and GAPDH, and 48 h 
for PDGF A-chain and  PDGF ~-receptor. (Lane 1) Whole  13-d- 
old embryos; (lanes 2-5) crude muscle from 15-, 17-, 18-, and 20- 
d-old embryos; (lanes 6--9) crude muscle from 1-, 7-, 14-, and 21-d- 
old rats; (lane 10) crude muscle from a 5-mo-old (adult)  rat. 
detect binding  of PDGF  to exponentially  proliferating  and 
terminally  differentiated  L6Jl  myoblasts.  Specificity  of the 
binding was determined  in the absence and presence of 300 
times excess of the corresponding unlabeled ligand. Preincu- 
bation  with  suramin,  which  previously  has been  shown  to 
dissociate PDGF from its receptors  (Williams et al.,  1984; 
Hosang,  1985),  was used in parallel experiments to dissoci- 
ate  binding  of endogenously  produced  PDGE  PDGF-BB 
specifically  bound  to  L6Jl  cells  (Fig.  3).  Exponentially 
proliferating myoblasts showed higher binding of PDGF-BB 
than  did  the  differentiated  myotubes,  indicating  a  higher 
number of PDGF/~-receptors  per  nucleus  on proliferating 
myoblasts than on myotubes.  Suramin pretreatment did not 
influence the binding of PDGF-AA or -BB (Fig. 3). Separate 
binding studies of PDGF purified from human platelets (Hei- 
din et al.,  1987) showed results similar to that of PDGF-BB 
(not shown).  PDGF purified from human platelets contains 
~70%  PDGF-AB and  30%  PDGF-BB.  Specific binding  of 
PDGF-AA to L6J1 myoblasts could not be demonstrated,  in- 
dicating  no or  very tow  amounts  of PDGF ct-receptors on 
these cells.  Results similar to the above described  were ob- 
tained  in three  separate experiments. 
PDGF-BB Transiently Induces c-fos lmmunoreactivity 
c-fos is an early response gene to PDGF treatment in various 
cell types (Kruijer et al.,  1984;  Miiiler et al.,  1984).  To see 
if  this  was  the  case  also  in  L6J1  myoblasts,  L6Jl  cells, 
deprived  of serum  for 4  d,  were  treated  with  25  ng/ml  of 
PDGF-BB,  and  fixed after different times, c-fos proteinlike 
staining  could  be detected  !  h  after  PDGF  treatment  (not 
shown), and maximal fluorescence was observed at 2 h (Fig. 
4).  The  nuclear  fluorescence  induced  by  PDGF  could  be 
blocked by preincubation  of the c-fos antiserum with an ex- 
cess of c-fos synthetic peptides (not shown),  indicating  spe- 
cific c-fos antibody  immunoreactivity.  The  intensity  of the 
nuclear  immunofluorescence  was  scanned  using  a  Zeiss/ 
Kontron  IBAS  2000  interactive  image  analysis  computer. 
Mean values and standard deviations of the optical densities, 
based on 250-300 nuclei for each sample, are shown in Fig. 
4 G. The experiment was repeated twice with similar results. 
DNA Synthesis and Differentiation in PDGF-Treated 
L6JI Myoblasts 
Having demonstrated the expression of the PDGF H-receptor 
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G  Figure 4.  Expression of c-fos 
immunoreactivity  in L6JI myo- 
blasts  deprived  of serum  for 
4 d (B), and in serum-deprived 
L6J1 myoblasts treated either 
with  25  ng/ml  of  porcine 
PDGF-BB (D), or 5 % FCS (F) 
for 2 h. Corresponding phase- 
contrast photographs are shown 
in A, C, and E. Cells were fixed 
with 4% paraformaldeh3xle  and 
incubated with  a  rabbit anti- 
fos antibody (xfos-3) followed 
by a TRITC-conjugated swine 
antirabbit IgG antibody. Nuclear  fluorescence was scanned using 
a Zeiss/Kontron IBAS 2000 interactive image analysis computer, 
setting background fluorescence to 1. Bar, 30 #m. (G) Mean values 
and  standard  deviations  of the  immunofluorescence  intensities 
based on 250-300 nuclei for each sample.  Significance level for 
comparison between 0 % FCS and 0 % FCS/PDGF-BB is indicated; 
***P < 0.01. 
gene, the specific membrane binding ability, and the induc- 
tion of c-fos protooncogene, it was of interest to study further 
the effects of PDGF on  DNA synthesis,  cell proliferation, 
and  myogenic  differentiation  of  L6J1  rat  myoblasts.  As 
shown in Fig. 5, low concentrations of PDGF-BB increased 
the percentage of BrdU-incorporating nuclei in the presence 
of 0.5%  FCS.  Half maximal stimulation of DNA synthesis 
was obtained with '~1 ng/ml of PDGF-BB.  At  10 ng/ml of 
PDGF-BB, the mitogenic activity reached a maximum. No 
further increase could be observed with higher concentra- 
tions of PDGF-BB. PDGF-AA did not affect DNA synthesis, 
except  for  a  marginal  increase  observed  at  45  ng/ml  of 
PDGF-AA,  the  highest  concentration  used  (Fig.  5).  The 
functional  activity of the  PDGF-AA preparation  used  has 
previously been shown (Heldin et al.,  1988). PDGF purified 
from human platelets increased L6J1 myoblast DNA synthe- 
sis by 25%  in the presence of 0.5%  FCS (data not shown). 
PDGF-BB,  PDGF-AA,  and  PDGF  purified  from  human 
platelets were not mitogenic for rat myoblasts in the absence 
of FCS (data not shown). Essentially similar results were ob- 
tained in three consecutive experiments. 
To analyze possible effects of PDGF  on  L6JI  myoblast 
proliferation,  we studied  proliferation of cells, deprived of 
serum for 4  d,  in the absence or presence of 25  ng/ml of 
PDGF-BB in 0.5 % FCS. As shown in Fig. 6, no stimulation 
of cell proliferation was seen during 7  d  in the  PDGF-BB 
containing  medium,  as compared to proliferation in 0.5% 
FCS. The experiment was repeated once with similar results. 
A possible explanation of the above described findings could 
be that PDGF exerts its effects only during the first cell cycle 
after  stimulation  of serum-deprived  myoblasts.  To  inves- 
tigate this possibility, we analyzed the increase in fractions 
of BrdU-incorporating nuclei during 0-24 h and 24-48 h af- 
ter addition of 25 ng/ml of PDGF-BB to the culture medium. 
As demonstrated in Fig. 7, the increase of cells present in the 
cell cycle after PDGF-BB treatment was markedly reduced 
during the 24-48-h time period as compared to the 0-24-h 
time period. 
To study possible effects of PDGF on L6JI myoblast spon- 
taneous in vitro differentiation,  myoblasts were cultured in 
DME/0.5%  FCS in the absence or presence of 25  ng/ml of 
PDGF-BB supplied daily. The percentage of nuclei present 
in myotubes was scored at different time points of the sponta- 
neous differentiation.  In the PDGF-BB containing medium 
7 % of the  nuclei were found in myotubes at day 4,  corre- 
sponding to 13% in the control medium. At day 7, 24%, and 
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Figure 5. Increase in DNA synthesis in L6JI myoblasts treated with 
recombinant  human  PDGF-AA  or  PDGF-BB.  Myoblasts  were 
seeded in DME/5%  FCS on coverslips at 6  x  103 cells/cm  2, and 
cultured in serum free DME for 4 d. The cells were then switched 
to DME/0.5 % FCS supplemented with 10/~M BrdU and various 
concentrations of either PDGF-AA or -BB for 24 h. Cell fixations 
and antibody reactions were carried out as described in Materials 
and Methods. Fractions of BrdU-incorporating  nuclei were deter- 
mined by counting 500-1,000 cells in randomly selected fields of 
vision, using a Zeiss ultraviolet microscope. Mean values and stan- 
dard deviations of triplicate  assays are shown.  Levels of BrdU- 
incorporation in nuclei without PDGF treatment have been adjusted 
to zero. 
0-24 h 
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Figure 7. Increase in DNA synthesis in L6J1 myoblasts treated with 
porcine  PDGF-BB. Myoblasts were seeded in DME/5%  FCS on 
coverslips at 6  x  10  3 cells/cm 2, and cultured in serum free DME 
for 4 d. After serum deprivation, cells were switched to DME/0.5 % 
FCS supplemented with various concentrations  of PDGF-BB.  10 
/~M of BrdU was added to the medium either 0-24 h or 24--48 h 
thereafter. Cell fixations and antibody reactions were carried out 
as described  in Materials  and  Methods.  Increase  in fractions  of 
BrdU-incorporating nuclei were determined by counting 500-1,000 
cells in randomly selected fields of vision, using a Zeiss ultraviolet 
microscope. Levels of BrdU-incorporation in nuclei without PDGF 
treatment have been adjusted to zero. 
at day  10 41%  of the  nuclei  were  present  in  myotubes in 
PDGF-BB-treated cultures. These contrasted with 36% and 
61% in the control cultures at day 7 and day 10, respectively. 
Thus, the formation of myotubes in PDGF-BB-treated L6JI 
myoblasts was reduced by '~30% at day 10. This assay was 
repeated once with essentially similar results. 
Discussion 
The results presented here show that the genes coding for the 
PDGF A-chain and the PDGF/~-receptor are expressed in 
rat myoblasts, and that PDGF-BB is a partial  mitogen for 
L6J1 rat myoblasts. Several polypeptide growth factors have 
in previous studies been shown to be mitogenic for estab- 
lished or primary rat myoblasts. These include insulin,  in- 
sulin-like growth factors I and II, fibroblast growth factor, 
transferrin, and growth hormone (Florini et al.,  1977;  Ew- 
ton and Florini, 1981; Hayachi and Kobylecki, 1982; Nissley 
et al., 1984; Massagud et al., 1986). Insulin-like growth fac- 
tors I and II have been shown to be produced by rat myoblasts 
and to stimulate cell growth in an autocrine manner (Nissley 
et al.,  1984). 
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Figure 6.  Proliferation  of L6J1 
myoblasts. Cells were seeded in 
DME/5% FCS at 4 x  l@/cm  2 in 
7-cm  2 wells, and cultured  in se- 
rum free DME for 4 d. Myoblasts 
were then maintained  in  DME/ 
0.5%  FCS  supplemented  with 
(---f:y--)  or without (~ 25 ng/ 
ml of porcine  PDGF-BB. At the 
indicated time points (days), myo- 
blasts were trypsinized,  and cell 
numbers were determined in trip- 
licate  wells  using  an automatic 
cell counter. 
At the RNA level, we found that the PDGF A-chain gene 
was expressed at all examined stages of rat myogenesis, in 
vitro and  in  vivo.  However, the  function of endogenously 
produced PDGF-AA on rat myoblasts is not clear, and ex- 
pression of its receptor remains to be examined using more 
sensitive methods. Our experiments showed that L6JI myo- 
blasts did not bind PDGF-AA, and only a marginal increase 
in DNA synthesis was observed with very high concentra- 
tions of PDGF-AA. 
Transcripts  for  the  PDGF  ~-receptor  were  present  in 
undifferentiated L6J1 rat myoblasts in vitro and in crude rat 
muscle tissue in vivo. PDGF ~-receptor mRNA was down- 
regulated in differentiated L6JI myotubes and mature adult 
rat muscle in a manner different from the expression pattern 
of PDGF A-chain transcripts. This was reflected also at the 
protein level as decreased capacity of L6J1 myotubes to bind 
PDGF-BB, compared to the binding capacity of proliferating 
L6J1  myoblasts.  It  should  further  be  commented  on  the 
PDGF binding experiments that the background binding, per 
nucleus,  was  consistently  found  to  be  much  higher  for 
proliferating  than  for  differentiated  myoblasts.  This  may 
partly be due to the large difference in cell density and free 
plastic surface area between the two states of differentiation 
analyzed, but other factors (e.g., altered membrane compo- 
sition) are also likely to have influenced the observed differ- 
ence in background binding. 
The presence of functional  PDGF  ~-receptors on  L6J1 
myoblasts was further supported by the PDGF-BB induced 
increase of c-fos immunoreactivity and the DNA synthesis 
induced by PDGF-BB; this form of PDGF was previously 
shown to bind to and act through the PDGF/~-receptor (Hart 
et al.,  1988;  Heldin et al.,  1988).  PDGF-BB is also likely 
to induce DNA synthesis in developing rat myoblasts in vivo, 
since they express PDGF/~-receptor mRNA. Surprisingly, 
PDGF-BB did not  increase the total cell number of L6J1 
myoblasts in proliferation assays, although it induced DNA 
synthesis. The lack of long term effect of growth factor on 
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finding that DNA synthesis was stimulated in serum-deprived 
myoblasts during the first 24 h after PDGF addition, but not 
during the next 24 h. The reason for this decreased respon- 
siveness to PDGF remains to be further analyzed. One fac- 
tor likely to contribute to the lack of proliferative effect is 
deficiency of other growth factors required by L6J1 myo- 
blasts. 
Myoblast  differentiation has  in  previous  studies  been 
shown to be inhibited or stimulated by various growth factors 
(Yaffe, 1971; Linkhart et al., 1980; Ewton and Florini, 1981; 
Lim and Hauschka, 1984;  Massagu6 et al.,  1986).  PDGF- 
BB partially inhibited myogenic differentiation in vitro, de- 
creasing myotube formation by ~30%. 
In conclusion, we have found that rat myoblasts express 
the PDGF A-chain gene and functional PDGF E-receptors. 
PDGF-BB induces c-fos immunoreactivity  and DNA synthe- 
sis, but not cell proliferation in short term assays. Myogenic 
differentiation of L6J1 myoblasts was inhibited by the pres- 
ence of PDGF-BB in the culture medium. 
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